The government has rolled out the schedule to administer the second dose of anti-COVID-19 vaccines from April 19 to April 22 to those who received the first shot between January 28 and February 22 earlier this year. As many as 500,000 doses of Covishield vaccine are currently in stock, as per officials. Issuing a public […]
Second dose of Covishield vaccine to be administered from Monday Read Post »
NEW DELHI, Jan 3 (Reuters) – India on Sunday granted emergency approval to Bharat Biotech’s COVAXIN but faced questions from industry experts and opposition lawmakers after taking the step without publishing efficacy data for the homegrown coronavirus vaccine. The news, announced by the drugs controller general of India (DCGI), was hailed by Prime Minister Narendra
India’s approval of homegrown vaccine criticised over lack of data Read Post »
Margaret Keenan, the 90-year-old grandmother who became the first person in the world to receive the Pfizer COVID-19 vaccine outside of a trial in Britain on Tuesday, has a message for others: “go for it” to beat the devastating disease. An early riser, Keenan, from Northern Ireland, received the Pfizer-BioNTech shot at her local hospital
‘Go for it,’ says grandmother who got world’s first Pfizer COVID vaccine in Britain Read Post »
SYDNEY/MELBOURNE, Aug 19 (Reuters) – A fresh outbreak of infections in Australia’s coronavirus hot zone of Victoria eased further on Wednesday, while the country agreed a deal to secure a potential COVID-19 vaccine that it plans to roll out cost-free to citizens. Australia has signed a deal with British drugmaker AstraZeneca to produce and distribute
German Health Minister Jens Spahn on Wednesday said Russia’s COVID-19 vaccine had not been sufficiently tested, adding the aim was to have a safe product rather than just being first to start vaccinating people. President Vladimir Putin announced on Tuesday that Russia had become the first country to grant regulatory approval to a COVID-19 vaccine
Germany says Russian COVID-19 vaccine has not been sufficiently tested Read Post »
Aawaaj News & Research is an independent news portal from Nepal reporting exclusively on social and political issues in a bid to raise awareness, inspire action, and bring about change on the same.
© 2023. ALL RIGHTS RESERVED
Aawaaj News and Research uses third-party cookies to improve performance and analyze traffic. By using the site, you consent to the collection of non-personal data, which you can manage or disable through your browser settings